Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Cleaved Caspase Motif
Cell Signaling Technology, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 61/410,479, filed Nov 5, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,249,231 | Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Cleaved Caspase Motif In force · High confidence UsedRemaining | Cell Signaling Technology, Inc. | In force | High confidence | ||
| US 11,377,486 | Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Sumoylated Lysine-Containing Residue In force · High confidence | Cell Signaling Technology, Inc. | In force | High confidence | ||
| US 12,577,295 | Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Sumoylated Lysine-Containing Residue In force · High confidence | Cell Signaling Technology, Inc. | In force | High confidence | ||
| Application 15/011,913 | Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Sumoylated Lysine-Containing Residue Abandoned Abandoned Sep 4, 2019 | Cell Signaling Technology, Inc. | Abandoned | Abandoned Sep 4, 2019 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Cell Signaling Technology, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.